Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins
Crossref DOI link: https://doi.org/10.1007/s40258-017-0336-8
Published Online: 2017-06-28
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McRae, Ian http://orcid.org/0000-0001-6200-7476
van Gool, Kees
Hall, Jane
Yen, Laurann
Funding for this research was provided by:
Australian Primary Health Care Research Institute, Australian National University
License valid from 2017-06-28